Last reviewed · How we verify
Seretide
Seretide is a Small molecule drug developed by GlaxoSmithKline. It is currently FDA-approved. Also known as: salmeterol xinafoate and fluticasone propionate, Symbicort compared with Seretide.
Seretide is a medication used to manage asthma and Chronic Obstructive Pulmonary Disease (COPD). It contains a combination of fluticasone, a glucocorticoid receptor agonist, and salmeterol, a long-acting beta2-adrenergic agonist.
At a glance
| Generic name | Seretide |
|---|---|
| Also known as | salmeterol xinafoate and fluticasone propionate, Symbicort compared with Seretide |
| Sponsor | GlaxoSmithKline |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Efficacy of Fluticasone Propionate Associated With Salmeterol Using Inhalation Chamber Versus Placebo to Improve the Respiratory Function in Children Over Six Years of Age Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation With a Decline of FEV1 ≥10% From Pre Transplantation (PHASE3)
- A Non- Inferiority Comparative Study Between Seretide® and Salmeterol/Fluticasone Eurofarma in Patients with Asthma (PHASE3)
- Study of Inhaled Glucocorticosteroids/Long-Acting Bronchodilator Drugs in Subjects With Asthma That Have Been Taking Inhaled Glucocorticosteroids (Study P04705AM1) (PHASE3)
- Study of Mometasone Furoate/Formoterol Combination and Fluticasone/Salmeterol in Persistent Asthmatics Previously Treated With Inhaled Glucocorticosteroids (P04139) (PHASE3)
- Single Dose Study of the Fluticasone/Salmeterol (500/50 μg) Administered With Elpenhaler® Versus Diskus® (PHASE3)
- Efficacy and Safety Study of Fluticasone/Salmeterol Administered With Elpenhaler (NA)
- Single Blind Cross-over Dose Response Study in Subjects of Two Inhalers of Salmeterol and Fluticasone Propionate (PHASE1)
- Salmeterol/Fluticasone 50/500 mcg Inhalation Powder Via Capsair vs Seretide Diskus 500 mcg Inhalation Powder in Patients With COPD (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Seretide CI brief — competitive landscape report
- Seretide updates RSS · CI watch RSS
- GlaxoSmithKline portfolio CI
Frequently asked questions about Seretide
What is Seretide?
Who makes Seretide?
Is Seretide also known as anything else?
What development phase is Seretide in?
Related
- Manufacturer: GlaxoSmithKline — full pipeline
- Therapeutic area: All drugs in Other
- Also known as: salmeterol xinafoate and fluticasone propionate, Symbicort compared with Seretide
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing